Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9Stivarga

02 1StivargaTM

PharmaCompass

01

Brand Name : Stivarga

Regorafenib

arrow
Antibody Engineering
Not Confirmed

Brand Name : Stivarga

arrow
Antibody Engineering
Not Confirmed

Regorafenib

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 575

2019 Revenue in Millions : 497

Growth (%) : 16

blank

02

Brand Name : Stivarga

Regorafenib

arrow
Antibody Engineering
Not Confirmed

Brand Name : Stivarga

arrow
Antibody Engineering
Not Confirmed

Regorafenib

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 525

2020 Revenue in Millions : 575

Growth (%) : 0

blank

03

Brand Name : Stivarga

Regorafenib

arrow
Antibody Engineering
Not Confirmed

Brand Name : Stivarga

arrow
Antibody Engineering
Not Confirmed

Regorafenib

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 644

2021 Revenue in Millions : 525

Growth (%) : 23

blank

04

Brand Name : Stivarga

Regorafenib

arrow
Antibody Engineering
Not Confirmed

Brand Name : Stivarga

arrow
Antibody Engineering
Not Confirmed

Regorafenib

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 567

2022 Revenue in Millions : 644

Growth (%) : -15

blank

05

Brand Name : Stivarga

Regorafenib

arrow
Antibody Engineering
Not Confirmed

Brand Name : Stivarga

arrow
Antibody Engineering
Not Confirmed

Regorafenib

Main Therapeutic Indication : Oncology

Currency : USD

2015 Revenue in Millions : 246

2014 Revenue in Millions : 344

Growth (%) : 40%

blank

06

Brand Name : StivargaTM

Regorafenib

arrow
Antibody Engineering
Not Confirmed

Brand Name : StivargaTM

arrow
Antibody Engineering
Not Confirmed

Regorafenib

Main Therapeutic Indication : Oncology

Currency : USD

2014 Revenue in Millions : 13.70%

2013 Revenue in Millions :

Growth (%) :

blank

07

Brand Name : Stivarga

Regorafenib

arrow
Antibody Engineering
Not Confirmed

Brand Name : Stivarga

arrow
Antibody Engineering
Not Confirmed

Regorafenib

Main Therapeutic Indication : Oncology

Currency : USD

2017 Revenue in Millions : 391

2016 Revenue in Millions : 341

Growth (%) : 15

blank

08

Brand Name : Stivarga

Regorafenib

arrow
Antibody Engineering
Not Confirmed

Brand Name : Stivarga

arrow
Antibody Engineering
Not Confirmed

Regorafenib

Main Therapeutic Indication : Oncology

Currency : USD

2018 Revenue in Millions : 356

2017 Revenue in Millions : 356

Growth (%) : 0%

blank

09

Brand Name : Stivarga

Regorafenib

arrow
Antibody Engineering
Not Confirmed

Brand Name : Stivarga

arrow
Antibody Engineering
Not Confirmed

Regorafenib

Main Therapeutic Indication : Oncology

Currency : USD

2016 Revenue in Millions : 292

2015 Revenue in Millions : 332

Growth (%) : -12

blank

10

Brand Name : Stivarga

Regorafenib

arrow
Antibody Engineering
Not Confirmed

Brand Name : Stivarga

arrow
Antibody Engineering
Not Confirmed

Regorafenib

Main Therapeutic Indication : Oncology

Currency : USD

2019 Revenue in Millions : 448

2018 Revenue in Millions : 343

Growth (%) : 30

blank